WHA’s president outlines plans to improve treatments for patients with hepatitis
Danjuma Adda, a Nigerian public health expert, became the president-elect of the World Hepatitis Alliance (WHA) in November last year. He is the first African to hold the position.
Having been infected and lost his mother to hepatitis B, Adda s personal experience has fueled his passion and drive for a paradigm shift in fighting the liver disease, which the WHO estimates affects 60 million Africans.
In an interview with
SciDev.Net, he outlined his plans to increase evidence-based research to improve treatments for patients with hepatitis, and investment commitments by African governments that will drive efforts to eliminate viral hepatitis.
Updated:
Gold nano particle-based diagnostic kit useful for early detection of HCV
Share Article
AAA
Gold nano particle-based diagnostic kit useful for early detection of HCV
COVID-19 is not the only virus haunting human beings. Hepatitis C Virus (HCV) is no less dangerous as it causes liver cirrhosis and cancers. “Find the Missing Millions” is the theme of the World Hepatitis Alliance (WHA) to show that millions are unaware of the asymptomatic conditions, and how critical it is to find those undiagnosed and linking them to clinical care.
The World Health Organisation (WHO) has set an ambitious target of eradicating HCV by 2030, which means extensive screening is imperative to completely eradicate the virus. Researchers at BITS Pilani, Hyderabad campus, have announced development of a gold nano particle-based diagnostic kit, which is cheaper and quicker for early-stage detection of HCV infection.
Danjuma Adda, the president-elect of the World Hepatitis Alliance. Copyright: Aspen Institute
Speed read
New president of World Hepatitis Alliance details efforts to eliminate viral hepatitis by 2030
African governments and other key actors such as pharmaceutical companies must do more
Share this article:
Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
You have to credit our authors.
You have to credit SciDev.Net where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.